Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
Year: 2015
Type: article
Source: European Heart Journal
Institutions: Uppsala University, University of Cincinnati, AstraZeneca (Sweden), Regional Hospital West Jutland, University Hospital Heidelberg, Inserm, Sorbonne Paris Cité, Royal Brompton Hospital, Assistance Publique – Hôpitaux de Paris, Laboratoire de Recherche Vasculaire Translationnelle, Hôpital Bichat-Claude-Bernard, Université Paris Diderot, University of Sheffield
Language: English
Topic: GDF15 and Related Biomarkers
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: growth differentiation factor 15, acute coronary syndrome, major bleeding, cardiovascular events, cardiovascular mortality, myocardial infarction, stroke, risk stratification, prognostic factors, ticagrelor, clopidogrel, PLATO trial, coronary artery disease extent, bleeding risk prediction, all-cause mortality, antiplatelet therapy, N-terminal pro-brain natriuretic peptide, cystatin C, high-sensitivity C-reactive protein, high-sensitivity troponin T
Open Access status: closed
OpenAlex ID: W2206428346
